Understanding how liver signaling affects obesity and insulin resistance
Novel Liver Signaling Pathways Controlling Adiposity
This study is looking at how a substance called bilirubin might help manage weight and improve insulin sensitivity in people with obesity or insulin resistance, by understanding how it works in the liver.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10812324 on NIH RePORTER |
What this research studies
This research investigates the role of bilirubin, a substance typically known for its antioxidant properties, in regulating fat accumulation and insulin sensitivity in the liver. The study aims to uncover how bilirubin interacts with specific receptors in the liver to influence metabolic processes, particularly in the context of obesity and related conditions like type II diabetes. By examining the mechanisms behind these interactions, the research seeks to provide insights into how liver health impacts overall metabolism and weight management. Patients with obesity or insulin resistance may find this research particularly relevant as it explores potential new pathways for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are obese or have insulin resistance, particularly those at risk for type II diabetes.
Not a fit: Patients with liver diseases unrelated to obesity or insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing obesity and improving insulin sensitivity in patients.
How similar studies have performed: Other research has shown promising results in exploring metabolic pathways related to obesity, suggesting that this approach may yield valuable insights.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Hinds, Terry D — University of Kentucky
- Study coordinator: Hinds, Terry D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.